IR News
Sep. 17, 2020Print(PDF/80KB)Corporate
Sumitomo Dainippon Pharma Announces Change in Executive Officer
Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following change in Executive Officer, effective October 1, 2020:
Change in Executive Officer
Change in the position assumed by Executive Officer (effective October 1, 2020)
| Position as of October 1, 2020 | Current position | Name |
|---|---|---|
|
Executive Officer Executive Research Director, Drug Research Division Senior Director, Research Planning & Coordination |
Executive Officer Executive Research Director, Drug Research Division |
Hideyuki Harada |